Product Image

Boswellia Extract 250 mg

NOW
4.7
★ ★ ★ ★ ★
(3907 ratings)
Boswellia 500 mg
Turmeric 200 mg
Product Image
Score81
Substantial boswellia and turmeric amounts provide good value. Active-marker and absorption details are incomplete, limiting potency confidence.
How scoring works
Quantity:120 Capsule(s) • (60 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 81

Substantial boswellia and turmeric amounts provide good value. Active-marker and absorption details are incomplete, limiting potency confidence.
How scoring works
$17.30($0.28 per serving)
Vitacost
$ 19.19
Pure Formulas
$ 17.30
Daily Vita
$ 17.40
iHerb
$ 18.36
Report prices

Analysis

Two capsules supply 500 mg boswellia extract and 200 mg each of turmeric extract and root powder. The formula clearly separates concentrated turmeric from plain root material and avoids hiding weights in a blend.

Boswellia and turmeric offer complementary pathway coverage, but the label does not quantify total boswellic acids, AKBA, or curcuminoids. Dry capsules without black pepper or lipid delivery may reduce practical active exposure.

Sixty servings and a low daily cost create good value for the disclosed amounts. It fits someone seeking a balanced combination rather than a highly standardized single active.

Who is it for
  • Adults seeking boswellia-curcumin capsules
  • Users who value clearly listed botanical weights
  • People who can screen herb-specific medication and tolerance concerns
Best for
  • Comparing botanical form and dose
  • Goal-aligned supplement selection
  • Users who prefer boswellia-curcumin capsules

Pros

  • Provides 500 mg boswellia extract
  • Includes turmeric extract and root powder
  • Sixty servings
  • Low serving cost

Cons

  • No boswellic-acid percentage
  • No AKBA amount
  • Curcuminoid yield is not stated
  • No absorption enhancer

Warnings

  • Turmeric may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Turmeric can aggravate symptoms in people with gallstones or bile-duct obstruction
  • Stop use if the concentrated botanicals cause persistent nausea, reflux, or abdominal discomfort

Nutrient quality

80 Highest impact

Meaningful boswellia and turmeric amounts create a focused inflammation-support formula. Active percentages and absorption support are not disclosed.

.

Ingredient transparency

82 Highest impact

Individual ingredient weights make the formula broadly readable. Missing active-marker yields and non-active ingredient details reduce full transparency.

.

Customer satisfaction

77 High impact

The supplied rating and large feedback base indicate consistently favorable satisfaction. No complaint-level evidence was supplied to assess recurring issues or purpose-specific experiences.

.

Value for money

87 Highest impact

The serving cost is favorable for the amount of formula provided. Potency and standardization gaps still reduce certainty about effective value.

.
Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB+ Strength of SupportA- CoverageA+ Formula Quality
Boswellia · 500 mg

Boswellia and turmeric combine complementary inflammatory signaling pathways, including 5-LOX modulation and curcuminoid activity. Both are present at meaningful labeled amounts, making the formula well aligned with joint and physical-comfort support.

Boswellic acids and curcuminoids are named, but percentages and absorption enhancement are not disclosed. Turmeric can increase bleeding tendency, so the 200 mg extract warrants caution with anticoagulant or antiplatelet medicines and before surgery.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
Highest effect
A Goal FitB Strength of SupportB+ CoverageA+ Formula Quality
Boswellia · 500 mg

Boswellia and turmeric directly support joint comfort and inflammatory balance through complementary botanical pathways. Both botanicals are supplied at useful disclosed amounts.

Boswellic-acid, AKBA, and curcuminoid percentages are not stated, and the dry capsule lacks an absorption enhancer. Turmeric may add to bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
Boswellia extract (Boswellic Acid, organic Acids)
500 mg
Turmeric root extract (Curcuminoids)
200 mg
Turmeric root powder
200 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Vegetarian
Report overview
F Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB- Value

The concentrated extract offers a substantial Boswellia amount, but the label does not state an active-acid percentage or AKBA content. Standard dry-capsule delivery supplies no absorption enhancer. The low serving cost is attractive, though uncertain standardization keeps the quality assessment moderate.

F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyB- Value

The active amount is meaningful for a curcumin-focused product. Source quality is limited by incomplete standardization details. A moderate active dose is offered below the collection midpoint.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  2. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS · Drug metabolism and personalized therapy · 2021
    Randomized trialAnti-Inflammatory Support forBoswellia
  3. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  4. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  5. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  6. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsAnti-Inflammatory Support Joint Health forBoswellia
  7. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  8. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  9. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  10. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia